Biocryst Pharmaceuticals Inc · Cash & Short-Term Investments

Latest reported$274.75Mperiod endingDec 31, 2025

BCRX FY Cash & Short-Term Investments ($2.70M → $274.75M)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

BCRX cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	274,747,000
Dec 31, 2024	321,060,000
Dec 31, 2023	388,987,000
Dec 31, 2022	424,310,000
Dec 31, 2021	507,601,000
Dec 31, 2020	300,366,000
Dec 31, 2019	136,226,000
Dec 31, 2018	126,843,000
Dec 31, 2017	155,692,000
Dec 31, 2016	63,576,000
Dec 31, 2015	99,246,000
Dec 31, 2014	113,888,000
Dec 31, 2013	40,637,000
Dec 31, 2012	36,750,000
Dec 31, 2011	41,718,000
Dec 31, 2010	53,945,539
Dec 31, 2009	68,963,749
Dec 31, 2008	61,528,462
Dec 31, 2007	50,697,513
Dec 31, 2006	37,457,566
Dec 31, 2005	50,260,399
Dec 31, 2004	23,173,095
Dec 31, 2003	20,028,000
Dec 31, 2002	24,448,807
Dec 31, 2001	31,987,188
Dec 31, 2000	24,635,310
Dec 31, 1999	23,100,000
Dec 31, 1998	12,300,000
Dec 31, 1997	3,800,000
Dec 31, 1996	3,600,000
Dec 31, 1995	6,100,000
Dec 31, 1994	2,700,000